Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Biocorrx Inc

Market Cap 95.88L 83.54L 77.01L 72.44L 1.36Cr 90Cr 1.36Cr 9.16Cr 3.56Cr 45Cr 3.6Cr 3.52Cr 154.35Cr P/E 2024
-0.78x
P/E 2025 -1.56x
Enterprise Value 1.16Cr 1.01Cr 93.09L 87.56L 1.64Cr 109.23Cr 1.65Cr 11Cr 4.3Cr 54Cr 4.35Cr 4.26Cr 186.57Cr EV / Sales 2024
1,004x
EV / Sales 2025 11.4x
Free-Float
38.64%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 58 09/11/2020
President 77 05/01/2024
Director TitleAgeSince
Director/Board Member 58 07/03/2013
Chairman 57 -
Director/Board Member 77 01/03/2019
Change 5-day change 1-year change 3-year change Capi.($)
-15.84%+6.09% - - 95.88L
-0.85%-2.15%+47.10%+45.19% 13TCr
-3.35%-0.88%-0.45%+29.33% 8.32TCr
+0.73%+5.36%-4.66%+55.71% 2.54TCr
-1.40%-4.33%+8.47%+40.69% 2.16TCr
+0.05%+2.59%-9.12%-22.77% 2.03TCr
-3.32%-0.35%+2.98%+120.03% 1.49TCr
-0.66%-3.02%-5.03%-1.20% 1.41TCr
+0.47%+2.00%+53.11%+112.98% 1.33TCr
-1.05%+3.20%-11.19%-4.66% 1.27TCr
Average -2.67%+0.78%+9.02%+41.70% 3.68TCr
Weighted average by Cap. -1.45%-0.50%+19.00%+39.74%

Financials

2024 2025
Net sales 7.66T 6.68T 6.16T 5.79T 10.83T 7L 10.91T 73.25T 28.45T 4L 28.77T 28.15T 12.34L 8L 7L 6L 6L 11.27L 7.51Cr 11.35L 76.18L 29.59L 3.7Cr 29.92L 29.28L 13Cr
Net income -51.06L -44.49L -41.01L -38.58L -72.17L -48Cr -72.68L -4.88Cr -1.89Cr -24Cr -1.92Cr -1.88Cr -82Cr -34.4L -29.97L -27.63L -25.99L -48.62L -32Cr -48.96L -3.29Cr -1.28Cr -16Cr -1.29Cr -1.26Cr -55Cr
Net Debt 27.18L 23.68L 21.83L 20.54L 38.42L 26Cr 38.69L 2.6Cr 1.01Cr 13Cr 1.02Cr 99.85L 44Cr 20.01L 17.44L 16.07L 15.12L 28.29L 19Cr 28.49L 1.91Cr 74.27L 9.3Cr 75.12L 73.51L 32Cr
Logo Biocorrx Inc
BioCorRx Inc. is an addiction treatment solutions company. The Company is engaged in offering treatment for substance use and other related disorders. Its Beat Addiction Recovery is a substance use disorder recovery program that typically includes its Cognitive Behavioral Therapy (CBT) modules along with peer support via mobile app, along with medication prescribed by an independent treating physician under their discretion. The UnCraveRx Weight Loss Program is also a medication-assisted weight-loss program that includes access to concierge on-demand wellness specialists, nutritionists, fitness experts, and personal support from behavioral experts. It also controls BioCorRx Pharmaceuticals Inc., a clinical-stage drug development subsidiary, which is seeking FDA approval for BICX104, an implantable naltrexone pellet for the treatment of alcohol and opioid use disorders. It is also engaged in the establishment of alcoholism and opioid addiction rehabilitation and treatment centers.
Employees
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!